BFA
AST

BlackRock Fund Advisors’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

BlackRock Fund Advisors’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.26M Buy
708,778
+96,547
+16% +$398K ﹤0.01% 3061
2016
Q3 		$2.6M Buy
612,231
+25,511
+4% +$82.5K ﹤0.01% 3100
2016
Q2 		$1.41M Buy
586,720
+313,067
+114% +$1.13M ﹤0.01% 3234
2016
Q1 		$1.29M Sell
273,653
-8,443
-3% -$32.7K ﹤0.01% 3162
2015
Q4 		$1.11M Buy
282,096
+7,795
+3% +$35.9K ﹤0.01% 3225
2015
Q3 		$1.06M Sell
274,301
-2,053
-0.7% -$9.43K ﹤0.01% 3205
2015
Q2 		$1.27M Buy
+276,354
New +$2.65M ﹤0.01% 3201

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return